Transport and travel

This overview is a guide to the content within the Regulatory (EU Law) subtopic with links to the appropriate materials. This subtopic examines EU regulations and directives which regulate the transport and travel sectors.

Introductory materials

To keep up to date with the changes in the travel and transport sector, see Practice Note: Travel/Transport—EU Regulatory tracker which tracks and summarises EU regulatory legislation guidance and other ongoing policy developments applicable to the transport and travel sector. More specifically, this tracker covers all live, closed and upcoming consultations, evaluations and proposals related to guidance, code of practice and legislation in this sector.

Practice Notes: Lexology Panoramic: Air Transport and Lexology Panoramic: Rail Transport provides an overview of the Air and Rail transport regulations in the EU as well as key EU Member States such as Belgium, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Netherlands, Poland, Portugal, Spain and Sweden.

Automated vehicles

An automated (or autonomous) vehicle (AV), is a vehicle with a collection of systems which remove the need for a human driver to control or even monitor functions such as steering, braking and acceleration and

To view the latest version of this document and thousands of others like it, sign-in with LexisNexis or register for a free trial.

TAKE A FREE TRIAL

Latest EU Law News

Amendments to draft Critical Medicines Act proposed to address impact of environmental over-regulation

The European Parliament’s Committee on the Environment, Climate and Food Safety has proposed key amendments to the draft Critical Medicines Act (CMA) to address the unintended consequences of overlapping environmental and chemical regulations on medicine supply. The committee acknowledges the importance of the EU’s environmental goals but warns that stricter rules—such as those on emissions, wastewater treatment, or substance restrictions—could raise production costs or push pharmaceutical manufacturing outside the EU. This could worsen medicine shortages and undermine the region’s competitiveness.

MedTech Europe publishes Reflection Paper calling on reform of diagnostic device sampling for certification

MedTech Europe has published a Reflection Paper calling on the Medical Device Coordination Group (MDCG) to adopt a risk-based, rather than quota-based, sampling approach for Class B and Class C devices to reduce the burden stemming from duplicative sampling and focus the resources of the system on higher risk devices. The industry body emphasises that in vitro diagnostic (IVD) device manufacturers have increased technical documentation and administrative burden under the Regulation (EU) 2017/746 (IVDR). Notified Bodies dedicate most of their time in sampling lower risk Class B and Class C devices, rather than highest risk Class D devices. Class B and C diagnostics together make up over 90% of the EU IVD market. The Paper notes that the average number of samples taken under IVDR is more than double that under the Medical Devices Regulation (MDR), due to broader scope codes and more grouping categories for IVDs. MedTech Europe in this Paper argues that the current system leads to repetitive sampling of the same devices, particularly for SMEs with limited portfolios, offering little added value in terms of safety or performance assurance. The Paper argues that the mandated 15% sampling rate for technical documentation per certification cycle is disproportionate, especially when compared to the 100% review requirement for the highest-risk Class D devices. This quota-based system imposes a significant financial and operational burden on manufacturers, with average costs per technical file review nearing €38,000. MedTech Europe proposes a shift to a risk-based sampling model. This seems to take a page from the UK which just had the UK Government respond to a public consultation in support of future regulation that will create a more proportionate risk-based approach to diagnostic device certification that would, in particular, mean that certification of Class B IVDs for the Great Britain market would require UKCA self-declaration and ISO 13485 quality management system (QMS) certification. MedTech Europe proposes to eliminate automatic quotas for Class B devices during surveillance, reducing sampling for Class C devices to 5%, and applying a maximum of 5% sampling during initial certification for devices with stable post-market surveillance. Simulations in the paper show that such an approach would significantly reduce the total cost burden on the sector without compromising safety. The paper calls for the MDCG to revise its guidance to reflect this more proportionate, risk-based strategy

EIOPA's July 2025 Insurance Risk Dashboard shows stable sector with areas of concern

The European Insurance and Occupational Pensions Authority (EIOPA) has published its July 2025 Insurance Risk Dashboard, based on Q1 2025 Solvency II data and Q2 2025 market data from 96 insurance groups and 2116 solo insurance undertakings. The report indicates stable medium-level risks across the European insurance sector, with strong capitalisation and improved non-life underwriting results. However, EIOPA flags concerns in market risks due to fixed income volatility, while cyber and ESG risks show an upward trend. The assessment highlights ongoing challenges from geopolitical tensions and trade uncertainties.

EU Law weekly highlights—31 July 2025

This week's edition of EU Law weekly highlights includes analyses on the Court of Justice’s ruling in CeramTev v Coorstek that held that the absolute grounds for invalidity under Regulation (EC) 207/2009 are autonomous but not mutually exclusive, the Unified Patent Court’s first injunction covering UK in Kodak case, the EU-US trade deal on 15% baseline tariff, the Commission’s guidelines for the protection of minors online under the EU Digital Services Act (EU DSA) and the Commission’s guidelines on the scope of obligations for general-purpose AI models. In addition this week, the European Parliament's Committee on Economic and Monetary Affairs adopted an opinion proposing significant amendments to EU corporate sustainability reporting requirements, the Agency for the Cooperation of Energy Regulators approved a new methodology for assessing national electricity flexibility needs, further, the Commission published a recommendation on voluntary sustainability reporting for SMEs, launched a call for evidence for an integrated framework for climate resilience and risk management across the EU, published guidelines for green bond disclosure templates, initiated the second stage of social partner consultations on proposed EU-level regulation of telework rights and the right to disconnect, and issued preliminary findings indicating that Temu, an online marketplace, may be in breach of the EU DSA.